0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > CD46

CD46

CD46 Molecule Information

Name:Membrane cofactor protein
Target Synonym:MCP?TLX?Trophoblast leukocyte common antigen?MIC10?CD46
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:3
Lastest Research Phase:Phase ?

CD46 Protein Product ListCompare or Buy

Cat. No. Species Product Description Structure Purity Feature
CD6-H5226 Human Human CD46 Protein
CD6-H5226-structure
CD6-H5226-sds

CD46 Molecule Synonym Name

CD46,AHUS2,MCP,MIC10,TLX,TRA2.10

CD46 Molecule Background

Complement regulatory protein CD46 is also known as membrane Cofactor Protein (MCP), is a type I membrane protein and is a regulatory part of the complement system. CD46 is expressed by all cells except erythrocytes. MCP acts as a cofactor for complement factor I, a serine protease which protects autologous cells against complement-mediated injury by cleaving C3b and C4b deposited on host tissue, and also acts as a costimulatory factor for T-cells which induces the differentiation of CD4+ into T-regulatory 1 cells. In T-cells by binding to CD46, A number of viral and bacterial pathogens seem to exploit this property and directly induce an immunosuppressive phenotype. Defects in CD46 are a cause of susceptibility to hemolytic uremic syndrome atypical type 2 (AHUS2).

CD46 References

CD46 Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Enadenotucirev ColoAd-1; Oncolytic Ad11/Ad3 Phase Ⅱ PsiOxus Therapeutics, Merck Sharp & Dohme Solid tumours, Colorectal cancer, Bladder cancer, Ovarian cancer Details
AugmAb BRM-132 Phase Ⅰ BRIM Biotechnology, PAI Life Sciences Cancer Details
FOR-46 FOR-46,FOR 46,FOR46 Phase Ⅰ Fortis Therapeutics Prostate cancer, Multiple myeloma (MM) Details

This web search service is supported by Google Inc.

totop